Navigation Links
Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
Date:2/2/2009

le. We are pleased with the progress of our partnership with the U.S. Government, which has resulted in this important milestone, and we are hopeful that fulfillment of this initial order will result in a long-term relationship involving additional deliveries of ABthrax to the Stockpile."

ABthrax represents a new way to address the anthrax threat. While antibiotics can kill the anthrax bacteria, they are not effective against the deadly toxins that the bacteria produce. ABthrax targets anthrax toxins after they are released by the bacteria into the blood and tissues. In an inhalation anthrax attack, people may not know they are infected with anthrax until the toxins already are circulating in their blood, and it may be too late for antibiotics alone to be effective.

"We are delighted to have fulfilled this important milestone under our contract with the U.S. Government and we hope we are making a significant contribution to our nation's security," said James H. Davis, Ph.D., J.D., Executive Vice President and General Counsel, HGS, and leader of the Company's ABthrax program with the U.S. Government. "We are particularly pleased with the relationship we have had with BARDA in the development of ABthrax, and we look forward to continuing to work together."

About Research Findings to Date

In December 2007, HGS announced that the results of two animal studies demonstrated the life-saving potential of ABthrax (raxibacumab). The results showed that a single dose of raxibacumab, administered without concomitant antibiotics, improved survival rates by up to 64 percent when administered after animals were symptomatic for anthrax disease as a result of inhalation exposure to massively lethal doses of anthrax spores. These dramatic and statistically significant findings demonstrated a survival benefit in two animal species, which is the requirement for establishing the efficacy of new drugs used to
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
2. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
3. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
4. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
5. 2008 Human Research Protection Award Recipients Announced
6. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
7. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
8. SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
9. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
10. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... NASHVILLE, Tenn. , July 22, 2014 ... will release second quarter 2014 financial results after the ... call and live Internet webcast will be held on ... to discuss the results. To participate in ... 253-237-1032 (for international callers).  A rebroadcast of the teleconference ...
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that the market ... will remain relatively stagnant at a value of around ... percutaneous coronary intervention (PCI) volumes are growing faster in ... as the United States and ... by the increase in penetration of PCI procedures relative to ...
(Date:7/22/2014)... Research and Markets  has announced the ... report to their offering. ... diagnose, monitor, and assess medical conditions, diseases, or infections ... for earlier and more targeted treatment. These tests are ... results. This kind of diagnostics provides early detection of ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3
... CALGARY, Alberta, July 13, 2011 Fero Industries, ... report that Merck S.A. de C.V. has successfully ... points-of-sale to over 2,500 outlets and pharmacy chains. ... well-known retailers including WalMart Supercenters, Superama, Farmacias del ...
... Schein, Inc. (NASDAQ: HSIC ), the largest provider ... the Henry Schein Cares Foundation, Inc., announced today a contribution ... help provide health care to those who have been affected ... earthquake in New Zealand, and tornadoes in the United States. ...
Cached Medicine Technology:Fero Industries Expands SucanonĀ® Distribution in Mexico 2Fero Industries Expands SucanonĀ® Distribution in Mexico 3Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 2Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 3
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society ... of the University of California Los Angeles with ... research in iron homeostasis, including the discovery of the ... iron metabolism. This award, named after the Nobel Prize ... recognizes pioneering research achievements in hematology that have represented ...
(Date:7/22/2014)... you eat pretty much everything you put on your ... study shows that the average adult eats 92% of whatever ... "If you put it on your plate, it,s going ... forthcoming book, Slim by Design, Professor of Marketing and Director ... co-author Katherine Abowd Johnson analyzed 1179 diners and concluded that ...
(Date:7/22/2014)... American Society of Hematology (ASH) will present the Society,s ... Lifetime Achievement in Hematology, to Kanti R. Rai, MD, ... of Medicine for his 50-year career combining landmark clinical ... exceptional patient care. , The Wallace H. Coulter ... an individual who has been a vital contributor to ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... 6th Latin American Conference on Lung Cancer (LALCA 2014) ... Lima, Peru. , Lung Cancer is still the leading ... worldwide. Building on the success of the previous conferences ... speakers will discuss the science and advances in the ... worldwide and Latin America in particular. , With tobacco ...
Breaking Medicine News(10 mins):Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Aug. ... Go for a walk after dinner. Play tag with your kids ... of exercise -- about 150 minutes, or 2.5 hours, of moderate ... by about 14 percent. Those who did more -- about ...
... -- Suicide is the 11th leading cause of death in ... taking their own lives. Sadly, each year tens of thousands ... family and friends, some warning signs exist. Often a simple ... a person toward help and treatment. A new ...
... While deformities of the lesser toes (all toes other than ... surgical and nonsurgical treatments for these conditions that are usually ... of the American Academy of Orthopaedic Surgeons (JAAOS) shows ... be symptoms of other conditions, early assessment and treatment by ...
... elderly people in the US, registered with Medicare, do not ... according to Dr. Larissa Nekhlyudov and colleagues from Harvard Medical ... and the National Cancer Institute, shows that cost-related medication non-adherence ... not filling in a prescription because it is too expensive ...
... CORAL GABLES, FL (August 1, 2011) Researchers from the ... Germany have developed a mathematical model to understand and predict ... metastasis, in hopes of creating highly personalized treatment strategies for ... new online journal Scientific Reports . When a ...
... 2011 Annual Meeting & OTO EXPO of the American ... (AAO-HNSF), the largest meeting of ear, nose, and throat ... in San Francisco, CA. Featuring more than 386 ... course hours for attendees, the annual meeting is a ...
Cached Medicine News:Health News:Even a Little Exercise Helps the Heart, Study Finds 2Health News:Even a Little Exercise Helps the Heart, Study Finds 3Health News:Mayo Clinic: Primary physicians may hold key to suicide prevention 2Health News:Don't suffer in silence with toe pain 2Health News:Barrier to effective treatment for seniors -- the cost of medicine 2Health News:Using math to fight cancer 2Health News:World's largest meeting of ear, nose and throat doctors 2
Y shape rotator tip. Shaft angled 7 mm from tip to bend. Round knurled handle with polished finish. Most popular size or model....
1.0 mm long 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
Delicate pick with 90 degree hook tip. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 110 degrees. Most popular size or model....
Medicine Products: